Trials / Recruiting
RecruitingNCT05886218
Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 215 (estimated)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Quantitative Neuromuscular Function Monitoring | Quantitative electromyographic (EMG) monitoring |
Timeline
- Start date
- 2023-02-08
- Primary completion
- 2025-07-01
- Completion
- 2025-07-01
- First posted
- 2023-06-02
- Last updated
- 2025-05-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05886218. Inclusion in this directory is not an endorsement.